More gene links to breast cancer risk
Oct. 19, 2012—Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.
Cell entry ports for cold virus
Sep. 25, 2012—The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.
Parkinson’s therapy may impact language
Sep. 7, 2012—Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests.
On the hunt for bladder cancer factors
Jul. 26, 2012—A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention.
Vanderbilt-led team to develop ‘microbrain’ to improve drug testing
Jul. 24, 2012—Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process.
Long antibodies better against HIV
Jul. 19, 2012—Understanding how antibodies with long “loops” form may be important for HIV vaccine development.
VU study finds stress fuels breast cancer metastasis to bone
Jul. 18, 2012—Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered.
Vanderbilt’s CTSA lands $46 million renewal
Jul. 12, 2012—Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million.
Gene’s impact on ‘good’ cholesterol could affect heart disease risk
Jul. 12, 2012—A genetic variant may help keep an individual’s “good” cholesterol in check.
Combo combats dizziness
Mar. 9, 2012—Some patients may need a combo of medications to combat a condition that causes dizziness.